The Strategic Partnership Gap: Why CDMOs Are Meeting Pharma's Expectations Less Than Half the Time with Simon-Kucher

About this episode

The episode discusses the execution gap in strategic partnerships between CDMOs and pharma, highlighting new research findings.

"Strategic partnerships — what a buzzword this has become in our industry." Kaan Fabian-Kekec and Clarita Havermeier at Simon-Kucher, unveiled exclusive new research at the start of CDMO Live Europe 2026. The research by Simon-Kucher and PharmaSource draws on 120+ senior executives across pharma and CDMOs globally. It reveals many areas of goal alignment, but highlights an execution gap as late-phase CDMOs are meeting established pharma's expectations just 44% of the time. The widest gaps are not quality or timelines. It's pricing and supply resilience.Listen to this recording from CDMO Live Europe 2026 and read the article

People in this episode

Guests: Kaan Fabian-Kekec, Clarita Havermeier

Topics covered

• strategic partnerships
• CDMOs
• pharma expectations
• research findings
• pricing
• supply resilience

Keywords

• CDMO
• pharma
• strategic partnerships
• expectations
• pricing
• supply resilience
• research
• executives

Mentioned in this episode

Organizations: Simon-Kucher, PharmaSource

More episodes of PharmaSource Podcast

• How Sanofi Navigates Regulatory CMC Across Global Markets: Insights from Manda Pasarkar · June 11, 2026 · 31 min
• The Politics Behind the Pipeline: How MFN Pricing and Tariffs Are Reshaping Pharma's Global Strategy · June 8, 2026 · 18 min
• How to Build a Resilient Global Vaccine Supply Chain: From Crisis to Capability · June 4, 2026 · 46 min
• How Lonza Is Outgrowing the CDMO Market with Bioconjugation, AI, and Regionalization · May 31, 2026 · 29 min
• Creative Financing Strategies for Biotech's Bear Market, Beyond the VC Round · May 25, 2026 · 29 min
• Decarbonizing Pharma: Why Green Chemistry Must Lead the Sustainability Agenda · May 18, 2026 · 27 min